Engineered lipid nanoparticles enable therapeutic gene silencing of GTSE1 for the treatment of liver fibrosis
Journal of Controlled Release · 2024-10 · 374 · 337-348
DOI: 10.1016/j.jconrel.2024.08.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-10. Verfasst von Michaela Jeong und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea. Hauptthemen laut MEDLINE: Liver Cirrhosis, Nanoparticles, Gene Silencing. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Center for Inter-University Research Facilities, Ministry of Food and Drug Safety, Korea Ministry of Science and ICT.
Abstract (Originalsprache)
Liver fibrosis is characterized by abnormal accumulation of extracellular matrix proteins, disrupting normal liver function. Despite its significant health impact, effective treatments remain limited. Here, we present the development of engineered lipid nanoparticles (LNPs) for targeted RNA therapeutic delivery in the liver. We investigated the therapeutic potential of modulating the G2 and S-phase expressed 1 (GTSE1) protein for treating liver fibrosis. Through screening, we identified P138Y LNP as a potent candidate with superior delivery efficiency and lower toxicity. Using these engineered LNPs, we successfully delivered siGTSE1 to hepatocytes, significantly reducing collagen accumulation and restoring liver function in a fibrosis animal model. Additionally, GTSE1 downregulation altered miRNA expression and upregulated hepatocyte nuclear factor 4 alpha (HNF4α). These findings suggest that therapeutic gene silencing of GTSE1 is a promising strategy for treating liver fibrosis by regenerating liver phenotypes and functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea.
- Department of Internal Medicine, Korea University Medical Center, Seoul 08308, Republic of Korea.
- College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea. Electronic address: wonhyoseo@ewha.ac.kr.
- College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea. Electronic address: hyukjin@ewha.ac.kr.
Förderung
- National Center for Inter-University Research Facilities
- Ministry of Food and Drug Safety
- Korea Ministry of Science and ICT
Zitieren
APA
Jeong, M., Shin, S., Lee, G., Lee, Y., Park, S. B., Kang, J., Lee, Y. S., Seo, W., & Lee, H. (2024). Engineered lipid nanoparticles enable therapeutic gene silencing of GTSE1 for the treatment of liver fibrosis. Journal of Controlled Release, 374, 337-348. https://doi.org/10.1016/j.jconrel.2024.08.012
Vancouver
Jeong M, Shin S, Lee G, Lee Y, Park SB, Kang J, et al. Engineered lipid nanoparticles enable therapeutic gene silencing of GTSE1 for the treatment of liver fibrosis. Journal of Controlled Release. 2024;374:337-348. doi:10.1016/j.jconrel.2024.08.012
BibTeX
@article{Jeong2024,
author = {Jeong, Michaela and Shin, Sumin and Lee, Gyeongseok and Lee, Yeji and Park, Seo Bhin and Kang, Jisoo and Lee, Young-Sun and Seo, Wonhyo and Lee, Hyukjin},
title = {Engineered lipid nanoparticles enable therapeutic gene silencing of GTSE1 for the treatment of liver fibrosis},
journal = {Journal of Controlled Release},
year = {2024},
volume = {374},
pages = {337--348},
doi = {10.1016/j.jconrel.2024.08.012}
}
EUVIMED